Skip to main content
Erschienen in: Virchows Archiv 6/2015

01.06.2015 | Original Article

Changes in autopsy rates among cancer patients and their impact on cancer statistics from a public health point of view: a longitudinal study from 1980 to 2010 with data from Cancer Registry Zurich

verfasst von: Uwe Bieri, Holger Moch, Silvia Dehler, Dimitri Korol, Sabine Rohrmann

Erschienen in: Virchows Archiv | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

During the last decades, autopsy rates have dramatically decreased in many countries. The Cancer Registry Zurich, which exists since 1980, provides the opportunity to address to what extent the number of autopsies in cancer patients has changed over a longer period of time and how often autopsies provide a diagnosis of clinically undetected cancer. Data from the Cancer Registry Zurich consisting of 102,434 cancer cases among 89,933 deceased patients between 1980 and 2010 were analyzed by means of descriptive statistics. The autopsy rate declined from 60 % in 1980 to 7 % in 2010. The total number of autopsies performed decreased from 1179 in 1986 to 220 in 2010. Furthermore, there was also a decline in the rate of newly detected tumours based on autopsy information. In 1980, the rate of newly detected tumours through autopsy was 42 % compared with 2010, when the rate had declined to 17 %. A consequence of the reduced autopsy rate is the reduction of incidental findings at autopsy in cancer registration. However, this reduction has not negatively affected the total incidence of cancer. It seems that the state-of-the-art diagnostic tools used for tumour detection are sufficiently reliable, allowing the scientific community to trust the quality of data provided by cancer registries in spite of decreasing autopsy rates.
Literatur
1.
Zurück zum Zitat Shojania KG, Burton EC, McDonald KM, Goldman L. The autopsy as an outcome and performance measure. Evidence report/technology assessment (summary). 2002;(58):1–5. Shojania KG, Burton EC, McDonald KM, Goldman L. The autopsy as an outcome and performance measure. Evidence report/technology assessment (summary). 2002;(58):1–5.
2.
Zurück zum Zitat Start RD, Firth JA, Macgillivray F, Cross SS, Road BH (1995) Have declining clinical necropsy rates reduced the contribution of necropsy to medical research? J Clin Pathol 48(5):402–404PubMedCentralPubMedCrossRef Start RD, Firth JA, Macgillivray F, Cross SS, Road BH (1995) Have declining clinical necropsy rates reduced the contribution of necropsy to medical research? J Clin Pathol 48(5):402–404PubMedCentralPubMedCrossRef
3.
Zurück zum Zitat Xiao J, Krueger GRF, Buja LM, Covinsky M (2009) The impact of declining clinical autopsy: need for revised healthcare policy. Am J Med Sci 337(1):41–46PubMedCrossRef Xiao J, Krueger GRF, Buja LM, Covinsky M (2009) The impact of declining clinical autopsy: need for revised healthcare policy. Am J Med Sci 337(1):41–46PubMedCrossRef
4.
Zurück zum Zitat Burton EC, McDonald KM, Goldman L, Page P (2003) Changes in rates of autopsy-detected. JAMA 289(21):2849–2856PubMedCrossRef Burton EC, McDonald KM, Goldman L, Page P (2003) Changes in rates of autopsy-detected. JAMA 289(21):2849–2856PubMedCrossRef
5.
Zurück zum Zitat Grinberg LT, da Silva Ferraz LF, Galtarossa Xavier AC, Nascimento Saldiva PH, Mauad T (2008) Clinico-pathological discrepancies in the diagnoses of solid malignancies. Pathol Res Pract 204(12):867–873PubMedCrossRef Grinberg LT, da Silva Ferraz LF, Galtarossa Xavier AC, Nascimento Saldiva PH, Mauad T (2008) Clinico-pathological discrepancies in the diagnoses of solid malignancies. Pathol Res Pract 204(12):867–873PubMedCrossRef
6.
Zurück zum Zitat Lundberg GD (1998) Low-tech autopsies in the era of high-tech medicine: continued value for quality assurance and patient safety. JAMA 280(14):1273–1274PubMedCrossRef Lundberg GD (1998) Low-tech autopsies in the era of high-tech medicine: continued value for quality assurance and patient safety. JAMA 280(14):1273–1274PubMedCrossRef
7.
Zurück zum Zitat Schwanda-Burger S, Moch H, Muntwyler J, Salomon F (2012) Diagnostic errors in the new millennium: a follow-up autopsy study. Mod Pathol 25(6):777–783PubMedCrossRef Schwanda-Burger S, Moch H, Muntwyler J, Salomon F (2012) Diagnostic errors in the new millennium: a follow-up autopsy study. Mod Pathol 25(6):777–783PubMedCrossRef
8.
Zurück zum Zitat Pastores SM, Dulu A, Voigt L, Raoof N, Alicea M, Halpern NA (2007) Premortem clinical diagnoses and postmortem autopsy findings: discrepancies in critically ill cancer patients. Crit Care 11(2):R48PubMedCentralPubMedCrossRef Pastores SM, Dulu A, Voigt L, Raoof N, Alicea M, Halpern NA (2007) Premortem clinical diagnoses and postmortem autopsy findings: discrepancies in critically ill cancer patients. Crit Care 11(2):R48PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Gradistanac T, Wittekind C (2011) Autopsy as a tool for quality assurance: Leipzig. Der Pathologe 32(Suppl 2):287–291PubMedCrossRef Gradistanac T, Wittekind C (2011) Autopsy as a tool for quality assurance: Leipzig. Der Pathologe 32(Suppl 2):287–291PubMedCrossRef
10.
Zurück zum Zitat Lindström P, Janzon L, Sternby NH (1997) Declining autopsy rate in Sweden: a study of causes and consequences in Malmö. Sweden. J Intern Med 242(2):157–165PubMedCrossRef Lindström P, Janzon L, Sternby NH (1997) Declining autopsy rate in Sweden: a study of causes and consequences in Malmö. Sweden. J Intern Med 242(2):157–165PubMedCrossRef
11.
Zurück zum Zitat Bode PK, Cathomas G, Vogt P, Moch H (2014) Klinische Autopsie. Praxis 103(2):65–71 Bode PK, Cathomas G, Vogt P, Moch H (2014) Klinische Autopsie. Praxis 103(2):65–71
12.
Zurück zum Zitat Chariot P, Witt K, Pautot V, Porcher R, Thomas G, Zafrani ES, Lemaire F (2000) Declining autopsy rate in a French hospital: physicians’ attitudes to the autopsy and use of autopsy material in research publications. Arch Pathol Lab Med 124(5):739–745PubMed Chariot P, Witt K, Pautot V, Porcher R, Thomas G, Zafrani ES, Lemaire F (2000) Declining autopsy rate in a French hospital: physicians’ attitudes to the autopsy and use of autopsy material in research publications. Arch Pathol Lab Med 124(5):739–745PubMed
14.
Zurück zum Zitat Statistik Stadt Zürich (2012) Statistisches Jahresbuch der Stadt Zürich, p. 72 Statistik Stadt Zürich (2012) Statistisches Jahresbuch der Stadt Zürich, p. 72
15.
Zurück zum Zitat Kircher T, Nelson J, Burdo H (1985) Descriptive epidemiology of the autopsy in Connecticut, 1979-1980. Arch Pathol Lab 109(10):904–909 Kircher T, Nelson J, Burdo H (1985) Descriptive epidemiology of the autopsy in Connecticut, 1979-1980. Arch Pathol Lab 109(10):904–909
16.
Zurück zum Zitat Nemetz PN, Ballard DG, Beard CN, Ludwig J, Tangalos EG, Kokmen E, Weigel KM, Belau PG, Bourne WM, Kurland LT (1989) An anatomy of the autopsy, Olmstead County, 1935 through 1985. Mayo Clin Proc 64:1055–1064PubMedCrossRef Nemetz PN, Ballard DG, Beard CN, Ludwig J, Tangalos EG, Kokmen E, Weigel KM, Belau PG, Bourne WM, Kurland LT (1989) An anatomy of the autopsy, Olmstead County, 1935 through 1985. Mayo Clin Proc 64:1055–1064PubMedCrossRef
18.
Zurück zum Zitat Gutzwiller F, Moch H, Probst-Hensch M. Institut für Sozial- und Präventivmedizin der Universität Zürich (2009, Hrsg.): Krebs im Kanton Zürich. Kurzbericht des Krebsregisters Gutzwiller F, Moch H, Probst-Hensch M. Institut für Sozial- und Präventivmedizin der Universität Zürich (2009, Hrsg.): Krebs im Kanton Zürich. Kurzbericht des Krebsregisters
19.
Zurück zum Zitat Baade PD, Youlden DR, Krnjacki LJ (2009) International epidemiology of prostate cancer: geographical distribution and secular trends. Mol Nutr Food Res 53(2):171–184PubMedCrossRef Baade PD, Youlden DR, Krnjacki LJ (2009) International epidemiology of prostate cancer: geographical distribution and secular trends. Mol Nutr Food Res 53(2):171–184PubMedCrossRef
20.
Zurück zum Zitat Konety BR, Bird VY, Deorah S, Dahmoush L (2005) Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era. J Urol 174(5):1785–1788PubMedCrossRef Konety BR, Bird VY, Deorah S, Dahmoush L (2005) Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era. J Urol 174(5):1785–1788PubMedCrossRef
21.
Zurück zum Zitat Scott RJ, Mutchnik DL, Laskowski TZ (1996) Carcinoma of the prostate in elderly men: incidence, growth characteristics and clinical significance. J Urol 101:602–607 Scott RJ, Mutchnik DL, Laskowski TZ (1996) Carcinoma of the prostate in elderly men: incidence, growth characteristics and clinical significance. J Urol 101:602–607
22.
Zurück zum Zitat Gaensbacher S, Waldhoer T, Berzlanovich A (2012) The slow death of autopsies: a retrospective analysis of the autopsy prevalence rate in Austria from 1990 to 2009. Eur J Epidemiol 27:577–580PubMedCrossRef Gaensbacher S, Waldhoer T, Berzlanovich A (2012) The slow death of autopsies: a retrospective analysis of the autopsy prevalence rate in Austria from 1990 to 2009. Eur J Epidemiol 27:577–580PubMedCrossRef
23.
Zurück zum Zitat Bamber AR, Quince TA, Barclay SI, Clark JD, Siklos PW, Wood DF (2014) Medical student attitudes to the autopsy and its utility in medical education: a brief qualitative study at one UK medical school. Anat Sci Educ 7(2):87–96PubMedCrossRef Bamber AR, Quince TA, Barclay SI, Clark JD, Siklos PW, Wood DF (2014) Medical student attitudes to the autopsy and its utility in medical education: a brief qualitative study at one UK medical school. Anat Sci Educ 7(2):87–96PubMedCrossRef
Metadaten
Titel
Changes in autopsy rates among cancer patients and their impact on cancer statistics from a public health point of view: a longitudinal study from 1980 to 2010 with data from Cancer Registry Zurich
verfasst von
Uwe Bieri
Holger Moch
Silvia Dehler
Dimitri Korol
Sabine Rohrmann
Publikationsdatum
01.06.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 6/2015
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-015-1734-7

Weitere Artikel der Ausgabe 6/2015

Virchows Archiv 6/2015 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …